Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.
In a report released today, Ryan Kenny from Morgan Stanley maintained a Buy rating on Evercore Partners (EVR – Research Report), with a price ...
KBW analyst Aidan Hall reiterated a Buy rating on Evercore Partners (EVR – Research Report) today and set a price target of $339.00. The ...
Confluent (NASDAQ:CFLT – Get Free Report) had its target price upped by Evercore ISI from $32.00 to $40.00 in a report ...
Canada Goose (NYSE:GOOS – Get Free Report) had its price objective dropped by investment analysts at Evercore ISI from $13.00 ...
1d
Hosted on MSNEvercore ISI Group Downgrades Trade Desk (TTD)Fintel reports that on February 13, 2025, Evercore ISI Group downgraded their outlook for Trade Desk (NasdaqGM:TTD) from ...
3d
Fintel on MSNEvercore ISI Group Upgrades TXNM Energy (TXNM)Fintel reports that on February 11, 2025, Evercore ISI Group upgraded their outlook for TXNM Energy (NYSE:TXNM) from In-Line ...
Walgreens Chief Executive Officer Tim Wentworth reiterated on an earnings call last month that the company plans to divest ...
Riverwater Partners Sustainable Value Strategy highlighted stocks like Evercore Inc. (NYSE:EVR) in its Q4 2024 investor letter. Headquartered in New York, New York, Evercore Inc. (NYSE:EVR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results